Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-26

Clinical Trial Update: Buproprion for Binge Drinking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bupropion for binge drinking showed completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Abuse | Phase 2 | Status: COMPLETED | Results posted: 2020-08-26